Publikationen von L. A. Pardo

Vieira, A. M.; Zahed, F.; Crispim, A. C.; de Souza Bento, E.; de Freitas Oliveira França, R.; Pinheiro, I. O.; Pardo, L. A.; Carvalho, B. M.: Production of levan from Bacillus subtilis var. natto and apoptotic effect on SH-SY5Y neuroblastoma cells. Carbohydrate Polymers 273, 118613 (2021)

Pedersen, S. F.; Flinck, M.; Pardo, L. A.: The interplay between dysregulated ion transport and mitochondrial architecture as a dangerous liaison in cancer. International Journal of Molecular Sciences 22 (10), 5209 (2021)

Ghazaryan, N.; Movsisyan, N.; Macedo, J. C.; Vaz, S.; Ayvazyan, N.; Pardo, L.; Logarinho, E.: The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model. Investigational new drugs, 10.1007/s1037-019-00734-2 (2019)

Barros, F.; Pardo, L. A.; Domínguez, P.; Sierra, L. M.; Peña, L. d. l.: New structures and gating of voltage-dependent potassium (Kv) channels and their relatives: A multi-domain and dynamic question. International Journal of Molecular Sciences 20 (2), 248 (2019)

Hernandez-Resendiz, I.; Hartung, F.; Pardo, L.: Antibodies Targeting KV Potassium Channels: A Promising Treatment for Cancer. Bioelectricity 1 (3), S. 180 - 187 (2019)

Moreels, L.; Bhat, C.; Vorácová, M.; Peigneur, S.; Goovaerts, H.; Mäki-Lohiluoma, E.; Zahed, F.; Pardo, L. A.; Yli-Kauhaluoma, J.; Kiuru, P. et al.; Tytgat, J.: Synthesis of novel purpurealidin analogs and evaluation of their effect on the cancer-relevant potassium channel Kv10.1. PLoS One 12 (12), e0188811 (2017)

Moreels, L.; Peigneur, S.; Galan, D. T.; De Pauw , E.; Béress, L.; Waelkens, E.; Pardo, L. A.; Quinton, L.; Tytgat, J.: APETx4, a novel sea anemone toxin and a modulator of the cancer-relevant potassium channel Kv10.1. Marine Drugs 15, 287 (2017)

Gomez-Lagunas, F.; Carrillo, E.; Pardo, L. A.; Stühmer, W.: Gating modulation of the tumor-related Kv10.1 channel by Mibefradil. Journal of Cellular Physiology 232 (8), S. 2019 - 2032 (2017)

Cázares-Ordonez, V.; Pardo, L. A.: Kv10.1 potassium channel: from the brain to the tumors. Biochemistry and Cell Biology-Biochimie et Biologie Cellulaire 95 (5), S. 531 - 536 (2017)

Tomczak, A. P.; Fernández-Trillo, J.; Bharill, S.; Papp, F.; Panyi, G.; Stühmer, W.; Isacoff, E. Y.; Pardo, L. A.: A new mechanism of voltage-dependent gating exposed by Kν10.1 channels interrupted between voltage sensor and pore. Journal of general physiology 149 (5), S. 577 - 593 (2017)

Martin, S.; Lazzarini, M.; Dullin, C.; Balakrishnan, S.; Gomes, F. V.; Ninkovic, M.; El-Hady, A.; Pardo, L. A.; Stühmer, W.; Del-Bel, E.: SK3 channel overexpression in mice causes hippocampal shrinkage associated with cognitive impairments. Molecular Neurobiology 54 (2), S. 1078 - 1091 (2017)

Pedersen, S. F.; Novak, I.; Alves, F.; Schwab, A.; Pardo, L. A.: Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer. Bioessays 39 (6), 1600253 (2017)

Urrego, D.; Sánchez, A.; Tomczak, A. P.; Pardo, L. A.: The electric fence to cell-cycle progression: Do local changes in membrane potential facilitate disassembly of the primary cilium? Bioessays 39 (6), 1600190 (2017)

Djamgoz, M. B. A.; Pardo, L.: Ion channels, transporters and cancer ("INCA2015"): an international meeting in honor of Prof. Dr. Walter Stühmer. European Biophysics Journal 45, S. 581 - 583 (2016)

Sánchez, A.; Urrego, D.; Pardo, L. A.: Cyclic expression of the voltage-gated potassium channel Kν10.1 promotes disassembly of the primary cilium. EMBO Reports 17, S. 708 - 723 (2016)

Hartung, F.; Pardo, L. A.: Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin. European Biophysics Journal 45, S. 709 - 719 (2016)

Napp, J.; Pardo, L. A.; Hartung, F.; Tietze, L. F.; Stühmer, W.; Alves, F.: In vivo imaging of tumour xenografts with an antibody targeting the potassium channel Kν10.1. European Biophysics Journal 45 (7), S. 721 - 733 (2016)

Ouadid-Ahidouch, H.; Ahidouch, A.; Pardo, L. A.: Kv10.1 K+ channel: from physiology to cancer. Pflügers Archiv: European Journal of Physiology 468 (5), S. 751 - 762 (2016)

Urrego, D.; Movsisyan, N.; Ufartes, R.; Pardo, L. A.: Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells. Cell Cycle 15 (6), S. 799 - 811 (2016)

Barrantes-Freer, A.; Renovanz, M.; Eich, M.; Braukmann, A.; Sprang, B.; Spirin, P.; Pardo, L. A.; Giese, A.; Kim, E. L.: CD133 expression is not synonymous to immunoreactivity for AC133 and fluctuates throughout the cell cycle in glioma stem-like cells. PLoS ONE 10 (6), e0130519 (2015)